We found that the functional genetic variant rs2243115 of IL12A, which encodes IL-12p35, a common subunit of IL-12 and IL-35, might play roles in CAD by regulating the IL-12/IL-35 pathway and affecting lipid levels and the inflammatory response, which provides a potential therapeutic target for CAD. This evidence concerns the gene IL12A and coronary artery disorder.